JODI KILLILEA: Open Payments
NPI 1235647066 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$503 in 27 payments from 13 companies in 2025. Trend: 2023 $243 · 2024 $108 · 2025 $503
Food & beverage: $503
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $76 |
| Aimmune Therapeutics, Inc. | 3 | $60 |
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
| Amgen Inc. | 3 | $45 |
| Novo Nordisk Inc | 3 | $44 |
| ViiV Healthcare Company | 2 | $38 |
| Astellas Pharma US Inc | 2 | $38 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| Dexcom, Inc. | 2 | $29 |
| Seqirus USA Inc | 1 | $25 |
Products named: ZENPEP, BOTOX, APRETUDE, Veozah, SHINGRIX, QULIPTA, OTEZLA, Wegovy.
Industry payments across CO — which companies pay providers there.
